Loading asset research
Xenetic Biosciences Inc. Common Stock
XBIONasdaq · USD · StocksQuote as of · Exchange session not verified$3.90
-4.18%
Today
XBIO
Loading 1D prices…
Market cap
$9.1M
Volume
37.7K
52w high
$13.9352w low
$1.90Company profile
Xenetic Biosciences Inc. Common Stock
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance. The company's product pipeline includes XBIO-015 for the treatment of pancreatic carcinoma and solid tumors; XBIO-020 for the treatment of solid tumors; and ErepoXen, which uses PolyXen platform technology for the treatment of anemia in chronic kidney disease (CKD) patients. It has a sublicensing agreement with Takeda Pharmaceutical Co. Ltd, as well as various research, development, license and supply agreements with Serum Institute of India, PJSC Pharmsynthez, and SynBio, LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Framingham, MA, United States
Employees
2
Fiscal year end
1231
CIK
1534525
Session & valuation
Open$4.07
Previous close$4.07
Day high$4.11
Day low$3.84
30-day avg. volume65.8K
Outstanding shares2.3M
Diluted EPS-$1.58
Latest annual period
P/E (trailing)-2.47
P/E (forward)-5.91
Price / book1.21
Beta2.24
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| XCURExicure Inc. Common Stock | $9.2M | $0.00 | — | -$0.79 | +2.19% | Unrated |
| SKYESkye Bioscience Inc. Common Stock | $9M | $0.00 | — | -$1.41 | -1.92% | Buy |
| GDTCCytoMed Therapeutics Limited Ordinary Shares | $9.3M | — | — | -$0.39 | -1.84% | Unrated |
| BFRGBullfrog AI Holdings Inc. Common Stock | $8.8M | $116.7K | -5569.61% | -$0.63 | -2.06% | Hold |
| ENSCEnsysce Biosciences Inc. Common Stock | $9.5M | $5.1M | -200.84% | -$3.98 | -5.62% | Unrated |